Drug Approval | April 24, 2025
Caplin Steriles gets USFDA approval for Phytonadione Injectable Emulsion
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Emcure has launched an awareness campaign to help spread the word about male anemia
HYMPAVZI’s approval is based on Phase 3 study results demonstrating non-inferiority and superiority compared to routine prophylaxis in eligible patients with hemophilia A or B without inhibitors
This product will be manufactured at Lupin’s Nagpur facility in India
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
Subscribe To Our Newsletter & Stay Updated
